ArticleTurkish thoracic journal2022

Response to Afatinib in a Common EGFR-Mutated Lung Adenocarcinoma with a Very Rare Combination of Compound Mutations.

Hiroaki Satoh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.